TY - JOUR
T1 - Social determinants of health and diabetes
T2 - A scientific review
AU - Hill-Briggs, Felicia
AU - Adler, Nancy E.
AU - Berkowitz, Seth A.
AU - Chin, Marshall H.
AU - Gary-Webb, Tiffany L.
AU - Navas-Acien, Ana
AU - Thornton, Pamela L.
AU - Haire-Joshu, Debra
N1 - Funding Information:
The findings and conclusion in this report are those of the authors and do not necessarily represent the official position of the Johns Hopkins ICTR, NCATS, NIH, NIDDK, or any other institution mentioned in the article. Duality of Interest. M.H.C. reports being co-coordinator of the “Bridging the Gap: Reducing Disparities in Diabetes Care National Program Office,” supported by the Merck Foundation, a consultant to the Patient-Centered Outcomes Group, and a member of the Bristol-Myers Squibb Company Health Equity Advisory Board. S.A.B. received personal fees for service on an advisory board about prioritizing food insecurity research topics for the Aspen Institute. T.L.G.-W. received personal fees for service on an advisory board about prioritizing food insecurity research topics for the Aspen Institute. No other potential conflicts of interests relevant to this article were reported. Author Contributions. F.H.-B. researched data and wrote the manuscript. N.E.A. contributed to writing and reviewing/editing the manuscript. S.A.B.researcheddataandcontributedtowriting and reviewing/editing the manuscript. M.H.C. contributed to writing and reviewing/editing the manuscript. T.L.G.-W. researched data and contributed to writing and reviewing/editing the manuscript. A.N.-A. researched data and contributed to writing the manuscript. P.L.T. researched data and contributed to writing and reviewing/editing the manuscript. D.H.-J. researched data and contributed to writing and reviewing/editing the manuscript.
Funding Information:
Acknowledgments. The authors express appreciation to Malaika I. Hill and Mindy Saraco of the American Diabetes Association; Elizabeth A. Vrany, Johns Hopkins University School of Medicine; and Shelly Johnson, Washington University in St. Louis, for providing technical assistance for this review. Funding. F.H.-B. is supported in part by the Johns Hopkins Institute for Clinical and Translational Research (ICTR), which is funded in part by grant UL1TR003098 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) and NIH Roadmap for Medical Research. F.H.-B. is also supported in part by NIH National Heart, Lung, and Blood Institute (NHLBI) grant T32HL07180. D.H.-J. is supported in part by NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant P30DK092950. M.H.C. is supported in part by NIH and NIDDK grant P30DK092949. T.L.G.-W. is supported in part by NHLBI grant R01HL131531. A.N.-A. is supported in part by National Institute of Environmental Health Sciences grants P42ES010349 and P30ES009089. S.A.B. is supported in part by NIDDK grant K23DK109200.
Publisher Copyright:
© 2020 by the American Diabetes Association.
PY - 2021/1
Y1 - 2021/1
N2 - Decades of research have demonstrated that diabetes affects racial and ethnic minority and low-income adult populations in the U.S. disproportionately, with relatively intractable patterns seen in these populations’ higher risk of diabetes and rates of diabetes complications and mortality (1). With a health care shift toward greater emphasis on population health outcomes and value-based care, social determinants of health (SDOH) have risen to the forefront as essential intervention targets to achieve health equity (2-4). Most recently, the COVID-19 pandemic has highlighted unequal vulnerabilities borne by racial and ethnic minority groups and by disadvantaged communities. In the wake of concurrent pandemic and racial injustice events in the U.S., the American College of Physicians, American Academy of Pediatrics, Society of General Internal Medicine, National Academy of Medicine, and other professional organizations have published statements on SDOH (5-8), and calls to action focus on amelioration of these determinants at individual, organizational, and policy levels (9-11). In diabetes, understanding and mitigating the impact of SDOH are priorities due to disease prevalence, economic costs, and disproportionate population burden (12-14). In 2013, the American Diabetes Association (ADA) published a scientific statement on socioecological determinants of prediabetes and type 2 diabetes (15). Toward the goal of understanding and advancing opportunities for health improvement among the population with diabetes through addressing SDOH, ADA convened the current SDOH and diabetes writing committee, prepandemic, to review the literature on 1) associations of SDOH with diabetes risk and outcomes and 2) impact of interventions targeting amelioration of SDOH on diabetes outcomes. This article begins with an overview of key definitions and SDOH frameworks. The literature review focuses primarily on U.S.-based studies of adults with diabetes and on five SDOH: Socioeconomic status (education, income, occupation); neighborhood and physical environment (housing, built environment, toxic environmental exposures); food environment (food insecurity, food access); health care (access, affordability, quality); and social context (social cohesion, social capital, social support). This review concludes with recommendations for linkages across health care and community sectors from national advisory committees, recommendations for diabetes research, and recommendations for research to inform practice.
AB - Decades of research have demonstrated that diabetes affects racial and ethnic minority and low-income adult populations in the U.S. disproportionately, with relatively intractable patterns seen in these populations’ higher risk of diabetes and rates of diabetes complications and mortality (1). With a health care shift toward greater emphasis on population health outcomes and value-based care, social determinants of health (SDOH) have risen to the forefront as essential intervention targets to achieve health equity (2-4). Most recently, the COVID-19 pandemic has highlighted unequal vulnerabilities borne by racial and ethnic minority groups and by disadvantaged communities. In the wake of concurrent pandemic and racial injustice events in the U.S., the American College of Physicians, American Academy of Pediatrics, Society of General Internal Medicine, National Academy of Medicine, and other professional organizations have published statements on SDOH (5-8), and calls to action focus on amelioration of these determinants at individual, organizational, and policy levels (9-11). In diabetes, understanding and mitigating the impact of SDOH are priorities due to disease prevalence, economic costs, and disproportionate population burden (12-14). In 2013, the American Diabetes Association (ADA) published a scientific statement on socioecological determinants of prediabetes and type 2 diabetes (15). Toward the goal of understanding and advancing opportunities for health improvement among the population with diabetes through addressing SDOH, ADA convened the current SDOH and diabetes writing committee, prepandemic, to review the literature on 1) associations of SDOH with diabetes risk and outcomes and 2) impact of interventions targeting amelioration of SDOH on diabetes outcomes. This article begins with an overview of key definitions and SDOH frameworks. The literature review focuses primarily on U.S.-based studies of adults with diabetes and on five SDOH: Socioeconomic status (education, income, occupation); neighborhood and physical environment (housing, built environment, toxic environmental exposures); food environment (food insecurity, food access); health care (access, affordability, quality); and social context (social cohesion, social capital, social support). This review concludes with recommendations for linkages across health care and community sectors from national advisory committees, recommendations for diabetes research, and recommendations for research to inform practice.
UR - http://www.scopus.com/inward/record.url?scp=85097821318&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85097821318&partnerID=8YFLogxK
U2 - 10.2337/dci20-0053
DO - 10.2337/dci20-0053
M3 - Review article
C2 - 33139407
AN - SCOPUS:85097821318
SN - 1935-5548
VL - 44
SP - 258
EP - 279
JO - Diabetes Care
JF - Diabetes Care
IS - 1
ER -